SLM produced porous titanium implant improvements for enhanced vascularization and osteoblast seeding

Zur Kurzanzeige

dc.identifier.uri http://dx.doi.org/10.15488/1595
dc.identifier.uri http://www.repo.uni-hannover.de/handle/123456789/1620
dc.contributor.author Matena, Julia
dc.contributor.author Petersen, Svea
dc.contributor.author Gieseke, Matthias
dc.contributor.author Kampmann, Andreas
dc.contributor.author Teske, Michael
dc.contributor.author Beyerbach, Martin
dc.contributor.author Murua Escobar, Hugo
dc.contributor.author Haferkamp, Heinz
dc.contributor.author Gellrich, Nils-Claudius
dc.contributor.author Nolte, Ingo
dc.date.accessioned 2017-05-31T11:36:48Z
dc.date.available 2017-05-31T11:36:48Z
dc.date.issued 2015
dc.identifier.citation Matena, Julia; Petersen, Svea; Gieseke, Matthias; Kampmann, Andreas; Teske, Michael et al.: SLM produced porous titanium implant improvements for enhanced vascularization and osteoblast seeding. In: International Journal of Molecular Sciences 16 (2015), Nr. 4, S. 7478-7492. DOI: https://doi.org/10.3390/ijms16047478
dc.description.abstract To improve well-known titanium implants, pores can be used for increasing bone formation and close bone-implant interface. Selective Laser Melting (SLM) enables the production of any geometry and was used for implant production with 250-microm pore size. The used pore size supports vessel ingrowth, as bone formation is strongly dependent on fast vascularization. Additionally, proangiogenic factors promote implant vascularization. To functionalize the titanium with proangiogenic factors, polycaprolactone (PCL) coating can be used. The following proangiogenic factors were examined: vascular endothelial growth factor (VEGF), high mobility group box 1 (HMGB1) and chemokine (C-X-C motif) ligand 12 (CXCL12). As different surfaces lead to different cell reactions, titanium and PCL coating were compared. The growing into the porous titanium structure of primary osteoblasts was examined by cross sections. Primary osteoblasts seeded on the different surfaces were compared using Live Cell Imaging (LCI). Cross sections showed cells had proliferated, but not migrated after seven days. Although the cell count was lower on titanium PCL implants in LCI, the cell count and cell spreading area development showed promising results for titanium PCL implants. HMGB1 showed the highest migration capacity for stimulating the endothelial cell line. Future perspective would be the incorporation of HMGB1 into PCL polymer for the realization of a slow factor release. eng
dc.description.sponsorship DFG/299/11-1
dc.language.iso eng
dc.publisher Basel : MDPI AG
dc.relation.ispartofseries International Journal of Molecular Sciences 16 (2015), Nr. 4
dc.rights CC BY 4.0 Unported
dc.rights.uri https://creativecommons.org/licenses/by/4.0/
dc.subject 0 (Chemokine CXCL12) eng
dc.subject 0 (HMGB1 Protein) eng
dc.subject 0 (Polyesters) eng
dc.subject 0 (Polymers) eng
dc.subject 0 (Vascular Endothelial Growth Factor A) eng
dc.subject 24980-41-4 (polycaprolactone) eng
dc.subject Animals eng
dc.subject Blood Vessels/drug effects/metabolism eng
dc.subject Cell Adhesion/drug effects eng
dc.subject Cell Movement/drug effects eng
dc.subject Cells, Cultured eng
dc.subject Chemokine CXCL12/metabolism eng
dc.subject D1JT611TNE (Titanium) eng
dc.subject Endothelial Cells/drug effects/metabolism eng
dc.subject Freezing eng
dc.subject HMGB1 Protein/metabolism eng
dc.subject Lasers eng
dc.subject Mice eng
dc.subject Mice, Inbred C57BL eng
dc.subject Neovascularization, Physiologic/drug effects eng
dc.subject Osteoblasts/drug effects/metabolism eng
dc.subject Osteogenesis/drug effects eng
dc.subject Polyesters/chemistry eng
dc.subject Polymers/chemistry eng
dc.subject Porosity eng
dc.subject Prostheses and Implants eng
dc.subject Surface Properties eng
dc.subject Titanium/administration & dosage eng
dc.subject Vascular Endothelial Growth Factor A/metabolism eng
dc.subject.ddc 540 | Chemie ger
dc.subject.ddc 570 | Biowissenschaften, Biologie ger
dc.title SLM produced porous titanium implant improvements for enhanced vascularization and osteoblast seeding eng
dc.type Article
dc.type Text
dc.relation.issn 1422-0067
dc.relation.doi https://doi.org/10.3390/ijms16047478
dc.bibliographicCitation.issue 4
dc.bibliographicCitation.volume 16
dc.bibliographicCitation.firstPage 7478
dc.bibliographicCitation.lastPage 7492
dc.description.version publishedVersion
tib.accessRights frei zug�nglich


Die Publikation erscheint in Sammlung(en):

Zur Kurzanzeige

 

Suche im Repositorium


Durchblättern

Mein Nutzer/innenkonto

Nutzungsstatistiken